Map of Pancreatica Walks and Runs

Category Archives: Pancreatic Cancer

IA and IV Gem and MITO-C

Recent advances over the drug agent gemcitabine for advanced pancreatic cancer are still in progress but appear to include the FOLFIRINOX (5-FU based) combination regimen and now recently Abraxane plus gemcitabine. Now comes a study by German researchers Lorenz and colleagues from the University of Frankfurt as published in the August issue of the journal […]

Share Button

FDA Approval: Nab-paclitaxel in Combination with Gemcitabine for Pancreatic Cancer

On September 6th the U.S Food and Drug Administration (FDA) – per its commendable fast track expedited review program for “orphan” diseases (which now includes pancreatic cancer) has approved nab-paclitaxel (trade name: Abraxane) for use in in combination with gemcitabine for metastatic pancreatic cancer. The previous drug agent officially approved by the FDA for pancreatic […]

Share Button

Chemotherapy Regimen for NET: Platinum Agent Plus Topoisomerase Inhibitor

The exploration of chemotherapy for advanced pancreatic neuroendocrine tumors has been somewhat sparse, but has increased pace during the past few years. Certain of these regimens have met with some success, increasing the armamentarium of clinicians. Beijing, China researchers led by Shen from the Peking University School of Oncology have published an article in the […]

Share Button
Page 16 of 31« First...10...1415161718...30...Last »